A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Crossbow Therapeutics, Inc.
Blueprint Medicines Corporation
Theradex
Solu Therapeutics, Inc
Ellipses Pharma
Aptose Biosciences Inc.
Cogent Biosciences, Inc.
Tr1X, Inc.
Epigenetix, Inc.